Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEDICAL CENTER

NPI: 1285703256 · SAN FRANCISCO, CA 94143 · Nuclear Medicine Physician · NPI assigned 11/06/2006

$156.89
Total Medicaid Paid
18,879
Total Claims
14,600
Beneficiaries
48
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialSHIVERS, JED (COO)
NPI Enumeration Date11/06/2006

Related Entities

Other providers sharing the same authorized official: SHIVERS, JED

ProviderCityStateTotal Paid
UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEDICAL CENTER SAN FRANCISCO CA $458K
UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEDICAL CENTER SAN FRANCISCO CA $15K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 3,114 $0.00
2019 4,289 $0.00
2020 5,289 $0.00
2021 1,983 $0.00
2022 912 $0.00
2023 1,253 $0.00
2024 2,039 $156.89

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
0450 Emergency room services 224 212 $148.80
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1,868 1,171 $8.09
81001 26 26 $0.00
80053 Comprehensive metabolic panel 1,111 712 $0.00
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 345 325 $0.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient 2,912 2,425 $0.00
0250 267 251 $0.00
Q3014 Telehealth originating site facility fee 961 852 $0.00
A9150 Non-prescription drugs 73 69 $0.00
80048 Basic metabolic panel (calcium, ionized) 401 291 $0.00
0301 204 195 $0.00
0636 100 93 $0.00
36415 Collection of venous blood by venipuncture 591 375 $0.00
0305 246 232 $0.00
J3490 Unclassified drugs 164 76 $0.00
0324 39 39 $0.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 381 352 $0.00
0306 76 74 $0.00
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 130 39 $0.00
85018 14 13 $0.00
85027 41 38 $0.00
71045 Radiologic examination, chest; single view 72 55 $0.00
83735 91 53 $0.00
86140 12 12 $0.00
0307 12 12 $0.00
84075 14 14 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 17 17 $0.00
99281 Emergency department visit for the evaluation and management, self-limited or minor 1,785 1,633 $0.00
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 1,375 911 $0.00
J7030 Infusion, normal saline solution , 1000 cc 470 247 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 42 41 $0.00
0272 261 226 $0.00
J8499 Prescription drug, oral, non chemotherapeutic, nos 1,464 705 $0.00
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,659 1,468 $0.00
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 113 106 $0.00
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 724 679 $0.00
0300 163 153 $0.00
71046 Radiologic examination, chest; 2 views 119 111 $0.00
J2405 Injection, ondansetron hydrochloride, per 1 mg 78 74 $0.00
82947 39 38 $0.00
0730 37 37 $0.00
82565 34 31 $0.00
82247 29 25 $0.00
0121 12 12 $0.00
84100 17 15 $0.00
0302 38 37 $0.00
84460 14 14 $0.00
84450 14 14 $0.00